Commons Sense

House of Commons · Ministers' Questions

Covid-19 Vaccines: Distribution

Tuesday 17 November 2020 · 2 questions

Summarised by AI from the official record, so it can contain mistakes.

Read the full transcript on Parliament.uk

At a glance

Answered 0 Partly answered 2 Not answered 0

Key points

  • Government plans for covid-19 vaccine distribution involve deploying the vaccine only after it meets robust standards through clinical trials and regulatory approval.
  • The NHS is preparing flexible distribution arrangements, including workforce planning, to ensure effective vaccine rollout.
  • The Minister acknowledged the logistical challenge of vaccine distribution and the need to ensure it includes everyone, without specifying a timeline.

Topics (select to filter)

Questions & Answers

Q1 Angela Eagle Lab Wallasey
NHS
Context

No specific background context given.

Question

What recent plans has the government made for the distribution of covid-19 vaccines?

Answer from Jo Churchill

A safe, effective vaccine will be deployed only after meeting robust standards through clinical trials and approval by the Medicines and Healthcare Products Regulatory Agency or an appropriate regulatory body. The NHS has been asked to prepare flexible distribution arrangements including workforce, training, consumables, and infrastructure to rapidly deliver a vaccination programme.

Partly answered

Not addressed: Specific timeline or logistical details of vaccine distribution were not provided

Was this summary accurate? Tell us

How accurate was this summary? (1 = poor, 5 = spot on)

Q2 Angela Eagle Lab Wallasey
NHS
Context

No specific background context given.

Question

Does the Minister agree that distribution will be a mammoth logistical effort, including everybody? Also, if people need two injections, how long will it take to safely vaccinate everyone in the country?

Answer from Jo Churchill

Acknowledging Liverpool's help with repatriation and mass testing, the Minister stated that while every effort is being made to deploy vaccines swiftly through regulatory approval and distribution at pace from manufacturers, no specific timeline was given due to process requirements.

Partly answered

Not addressed: Specific logistical efforts and timelines were not provided

Was this summary accurate? Tell us

How accurate was this summary? (1 = poor, 5 = spot on)